The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
A type of drugs made of protein. These drugs usually have large molecular weight with proteincharacteristics.
The global Protein Drugs market was valued at US$ 266900 million in 2023 and is anticipated to reach US$ 439710 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.
However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Protein Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Drugs.
Report Scope
The Protein Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Protein Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Protein Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Eli Lilly
- Abbott Laboratories
- UCB Group
- Schering-Plough Corporation
- Genentech
- Johnson＆Johnson
- Bristol-Myers Squibb
- Novo Nordisk
- Biogen Idec
- Dendreon Corporation
- Amgen Inc.
Segment by Type
- Antibody Drugs
- Peptide Hormones
- Blood Products
- Enzymes
Segment by Application
- Hospitals
- Clinics
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Protein Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Protein Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibody Drugs
1.2.3 Peptide Hormones
1.2.4 Blood Products
1.2.5 Enzymes
1.3 Market by Application
1.3.1 Global Protein Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Protein Drugs Market Perspective (2019-2030)
2.2 Protein Drugs Growth Trends by Region
2.2.1 Global Protein Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Protein Drugs Historic Market Size by Region (2019-2024)
2.2.3 Protein Drugs Forecasted Market Size by Region (2025-2030)
2.3 Protein Drugs Market Dynamics
2.3.1 Protein Drugs Industry Trends
2.3.2 Protein Drugs Market Drivers
2.3.3 Protein Drugs Market Challenges
2.3.4 Protein Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Protein Drugs Players by Revenue
3.1.1 Global Top Protein Drugs Players by Revenue (2019-2024)
3.1.2 Global Protein Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Protein Drugs Revenue
3.4 Global Protein Drugs Market Concentration Ratio
3.4.1 Global Protein Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Protein Drugs Revenue in 2023
3.5 Protein Drugs Key Players Head office and Area Served
3.6 Key Players Protein Drugs Product Solution and Service
3.7 Date of Enter into Protein Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Protein Drugs Breakdown Data by Type
4.1 Global Protein Drugs Historic Market Size by Type (2019-2024)
4.2 Global Protein Drugs Forecasted Market Size by Type (2025-2030)
5 Protein Drugs Breakdown Data by Application
5.1 Global Protein Drugs Historic Market Size by Application (2019-2024)
5.2 Global Protein Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Protein Drugs Market Size (2019-2030)
6.2 North America Protein Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Protein Drugs Market Size by Country (2019-2024)
6.4 North America Protein Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Protein Drugs Market Size (2019-2030)
7.2 Europe Protein Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Protein Drugs Market Size by Country (2019-2024)
7.4 Europe Protein Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Protein Drugs Market Size (2019-2030)
8.2 Asia-Pacific Protein Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Protein Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Protein Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Protein Drugs Market Size (2019-2030)
9.2 Latin America Protein Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Protein Drugs Market Size by Country (2019-2024)
9.4 Latin America Protein Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Protein Drugs Market Size (2019-2030)
10.2 Middle East & Africa Protein Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Protein Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Protein Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Protein Drugs Introduction
11.1.4 Eli Lilly Revenue in Protein Drugs Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Protein Drugs Introduction
11.2.4 Abbott Laboratories Revenue in Protein Drugs Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 UCB Group
11.3.1 UCB Group Company Detail
11.3.2 UCB Group Business Overview
11.3.3 UCB Group Protein Drugs Introduction
11.3.4 UCB Group Revenue in Protein Drugs Business (2019-2024)
11.3.5 UCB Group Recent Development
11.4 Schering-Plough Corporation
11.4.1 Schering-Plough Corporation Company Detail
11.4.2 Schering-Plough Corporation Business Overview
11.4.3 Schering-Plough Corporation Protein Drugs Introduction
11.4.4 Schering-Plough Corporation Revenue in Protein Drugs Business (2019-2024)
11.4.5 Schering-Plough Corporation Recent Development
11.5 Genentech
11.5.1 Genentech Company Detail
11.5.2 Genentech Business Overview
11.5.3 Genentech Protein Drugs Introduction
11.5.4 Genentech Revenue in Protein Drugs Business (2019-2024)
11.5.5 Genentech Recent Development
11.6 Johnson＆Johnson
11.6.1 Johnson＆Johnson Company Detail
11.6.2 Johnson＆Johnson Business Overview
11.6.3 Johnson＆Johnson Protein Drugs Introduction
11.6.4 Johnson＆Johnson Revenue in Protein Drugs Business (2019-2024)
11.6.5 Johnson＆Johnson Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Protein Drugs Introduction
11.7.4 Bristol-Myers Squibb Revenue in Protein Drugs Business (2019-2024)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Novo Nordisk
11.8.1 Novo Nordisk Company Detail
11.8.2 Novo Nordisk Business Overview
11.8.3 Novo Nordisk Protein Drugs Introduction
11.8.4 Novo Nordisk Revenue in Protein Drugs Business (2019-2024)
11.8.5 Novo Nordisk Recent Development
11.9 Biogen Idec
11.9.1 Biogen Idec Company Detail
11.9.2 Biogen Idec Business Overview
11.9.3 Biogen Idec Protein Drugs Introduction
11.9.4 Biogen Idec Revenue in Protein Drugs Business (2019-2024)
11.9.5 Biogen Idec Recent Development
11.10 Dendreon Corporation
11.10.1 Dendreon Corporation Company Detail
11.10.2 Dendreon Corporation Business Overview
11.10.3 Dendreon Corporation Protein Drugs Introduction
11.10.4 Dendreon Corporation Revenue in Protein Drugs Business (2019-2024)
11.10.5 Dendreon Corporation Recent Development
11.11 Amgen Inc.
11.11.1 Amgen Inc. Company Detail
11.11.2 Amgen Inc. Business Overview
11.11.3 Amgen Inc. Protein Drugs Introduction
11.11.4 Amgen Inc. Revenue in Protein Drugs Business (2019-2024)
11.11.5 Amgen Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
